Hongbo Lu, Director of Zenas BioPharma ZBIO, has filed 11 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $6.9M. The latest trade was on 06/15.

HL

HL

Hongbo Lu

Director

Company

Zenas BioPharma ZBIO

First filing

23/06/14

Trades

22 trades

Buys / sales

11 / 1

12-month net buying

$6.9M

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Arrowhead PharmaceuticalsARWR	Open-market sale10b5-1 plan	05/12	05/14	2,970 sh	$76.88	$228,333.6	−5.4%
Zenas BioPharmaZBIO	Open-market buy	03/31	04/02	3,768 sh	$18.63	$70,197.84	+0.9%
Zenas BioPharmaZBIO	Open-market buy	03/31	03/31	75,000 sh	$20.00	$1,500,000	+21.6%
Zenas BioPharmaZBIO	Open-market buy	02/11	02/13	25,985 sh	$22.50	$584,662.5	+8.1%
Zenas BioPharmaZBIO	Open-market buy	24/09/13–25/10/07	25/10/09	321,983 sh2 trades	$18.63avg.	$6,000,031	No record
Zenas BioPharmaZBIO	Open-market buy	24/09/13	24/09/17	58,823 sh	$17.00	$999,991	No record
TP Terns Pharmaceuticals	Open-market buy	24/09/12	24/09/17	476,190 sh2 trades	$10.50avg.	$4,999,995	No record
Arrowhead PharmaceuticalsARWR	Open-market buy	24/03/18–24/03/20	24/03/20	3,000 sh3 trades	$27.66avg.	$82,990	+9.8%